TABLE 4.

Functional data and pain symptoms at preoperative evaluation and 3‐month follow up of parametrectomy group (P) and non‐parametrectomy group (NP)

	Preoperative			Postoperative
	Group P (n = 69)	Group NP (n = 31)	P value	Group P (n = 69)	Group NP (n = 31)	P value
Dyschezia VAS	0 (0–10)	3 (0–10)	0.194	0 (0–9)	0 (0–10)	0.783
Dysmenorrhea VAS	8 (0–10)	7 (0–10)	0.230	0 (0–10)	0 (0–8)	0.228
Dysuria VAS	0 (0–9)	0 (0–7)	0.224	0 (0–8)	0 (0–1)	0.415
Dyspareunia VAS	6 (0–10)	3 (0–10)	0.055	0 (0–8)	0 (0–3)	0.049
Chronic pelvic pain VAS	5 (0–10)	3 (0–10)	0.595	0 (0–8)	0 (0–8)	0.316
KESS total score	15 (3–29)	14 (2–25)	0.609	11 (0–28)	10 (0–31)	0.861
GIQLI total score	87 (42–129)	90 (8–105)	0.849	104 (59–139)	105 (60–138)	0.602
Constipation (KESS ≥10)	48 (69.6)	24 (77.4)	0.419	41 (59.4)	19 (61.3)	0.860
FSFI total score	21.6 (2–34)	23.7 (14–31)	0.101	24.4 (2–36)	26.1 (2–31)	0.397
BFLUTS total score	7 (0–30)	3 (1–58)	0.093	6 (0–34)	3 (1–36)	0.143
FSD (FSFI score <26.5)	45 (65.2)	20 (64.5)	0.946	39 (56.5)	10 (32.3)	0.025

Abbreviations: BFLUTS, the Bristol Female Lower Urinary Tract Symptom Questionnaire; FSD, female sexual dysfunction; FSFI, the Female Sexual Function Index; GIQLI, the Gastrointestinal Quality of Life Index; KESS, Knowles‐Eccersley‐Scott‐Symptom Questionnaire; VAS, visual analog scale.

^a Values are presented as median (range; expressed as minimum‐maximum) or as number (percentage).